Yufi
Search My account
A

ADBDL Médecine et Sciences médicales

Active companySociété à responsabilité limitéeBE 1004.803.303
Registered officeWavre
Founded2024
Headcount1-4 people
Locations1 establishments
Contact Visit website Add to a list
A
Product universe
72.101 · Recherche-développement en biotechnologie

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Sign in for the complete view

Identity, activity, filings and a two-year financial snapshot — like the public profile.

Company summary

Not provided

Gross margin 2024
46.6 k€
—
Net result 2024
32.6 k€
Positive result
Headcount
1-4
Microstructure
Establishments
1
1 municipalities

Activities and NACE codes

Every code, not only the principal activity.
All NACE codes
Recherche-développement en biotechnologie (72101)

Visuals

Logo, products and brand world.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Sign in for the complete view

Legal publications

Official sources, with a link to the detail.
Belgian Official Gazette — eJustice Deeds, articles, appointments Open Central Balance Sheet Office — NBB Financial analysis and latest accounts Open Establishments Operating sites · 1 Open Social security NSSO size band and employer file Open

Map and locations

Registered office and establishments.
HQ Sites 1 · 1 municipalities

Establishment list

HQ · Wavre

Avenue Prince de Vaudémont 6, 1300 Wavre

Establishment unit 2.355.420.415 · Since 2024-01-17

Activities at this site

8
72.101 · Recherche-développement en biotechnologie86.220 · Activités de médecine spécialisée86.210 · Activités de médecine générale82.300 · Organisation de salons professionnels et congrès72.109 · Recherche-développement en autres sciences physiques et naturelles74.999 · Autres activités des professions libérales et autres activités scientifiques et techniques, nca85.599 · Autres formes d'enseignement86.995 · Activités dans le domaine de l’alimentation

Source BCE / KBO

Financial analysis

Ratios, structures, last two years and commentary.
See moreFinancial year 2024
Total assets65.4 k€—
Equity33.6 k€—
Liabilities31.7 k€—
Cash46.7 k€—
Solvency51 %—
Liquidity1.73—
ROE97 %—
Customer payment term10 d—

Last two years

20242023Trend
Gross margin46.6 k€—
—
Net result32.6 k€—
—
Equity33.6 k€—
—
Liabilities31.7 k€—
—
Cash46.7 k€—
—

Team and key contacts

Directors, legal representative and link to the company profile.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Sign in for the complete view

Products, what the company does, opportunities, events and key people.

What the company does

Offers, origin and prospecting angles.
Purpose

Not provided

Origin

Not provided

Founders

Not provided

Key registration

72.101 · Recherche-développement en biotechnologie

Flagship offers

Not provided

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Sign in for the complete view

Visuals

Logo, products and brand world.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Sign in for the complete view

Contact details

Phone and email found on the website or Google.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Sign in for the complete view

Team

People identified on the company website.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Sign in for the complete view

Events

Summary, status and source document.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Sign in for the complete view

Headcount, workplaces, social balance and people you would meet.

For candidates

This page is for recruiters. Candidate openings are on ilovemy.jobs.
See candidate openings on ilovemy.jobs

Jobs found

Internal openings and client assignments found on the website.

No jobs found at the moment

Employer

Headcount and HR reading, before the openings.
Founded

2024

Locations

1 establishments

Headcount trend

No multi-year FTE series yet.

Male / female split

No male / female split published for this year.

Full-time / part-time split

No full-time / part-time split extracted for this year.

Management / employees / workers / other

No occupational-category split extracted for this year.

Temporary agency / permanent staff

Not extracted from the social balance. Published FTE is this company’s registered staff, not people placed on assignment.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Sign in for the complete view

Workplaces

Registered office and establishments.
HQ Sites 1 · 1 municipalities

Establishment list

HQ · Wavre

Avenue Prince de Vaudémont 6, 1300 Wavre

Establishment unit 2.355.420.415 · Since 2024-01-17

Activities at this site

8
72.101 · Recherche-développement en biotechnologie86.220 · Activités de médecine spécialisée86.210 · Activités de médecine générale82.300 · Organisation de salons professionnels et congrès72.109 · Recherche-développement en autres sciences physiques et naturelles74.999 · Autres activités des professions libérales et autres activités scientifiques et techniques, nca85.599 · Autres formes d'enseignement86.995 · Activités dans le domaine de l’alimentation

Source BCE / KBO

Jobs

Internal roles at this company — careers pages, process and contacts.
0

Contacts

Not yet extracted from job files.

No careers page or internal opening identified yet.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Sign in for the complete view

Structure, ratios and multi-year analysis.

Financial analysis

Ratios, structures, last two years and commentary.
Financial year 2024
Total assets65.4 k€—
Equity33.6 k€—
Liabilities31.7 k€—
Cash46.7 k€—
Solvency51 %—
Liquidity1.73—
ROE97 %—
Customer payment term10 d—

Last two years

20242023Trend
Gross margin46.6 k€—
—
Net result32.6 k€—
—
Equity33.6 k€—
—
Liabilities31.7 k€—
—
Cash46.7 k€—
—

Detailed financial analysis

Trends, ratios and a reading of the retrieved years.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Sign in for the complete view